Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

People with severe hair loss have higher levels of a protein called interleukin 17 in their blood.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

miR-21 increases skin aging by reducing SATB1, affecting skin cell function.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Interleukin 6 may help protect skin without causing inflammation.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

CS12192 effectively treats alopecia areata with better safety than current options.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Collagen XXII is a marker for tissue junctions, aiding in structural integrity and found in muscles, heart, skin, and arthritic joints.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

miR‑339‑5p can slow down hair follicle stem cell differentiation by targeting DLX5.

Anti-CD19 therapy may help treat SLE and NMOSD.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Blocking IL-17a can improve age-related smell loss in mice.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Disrupting the Sox21 gene in mice causes hair loss and regrowth cycles.